de
en
de
en
International
About us
BERLIN-CHEMIE
MENARINI Group
Our History
Our Goal
Executive Board
Responsibility
Code of Conduct
Sustainability & social commitment
Code of practice for business partners
Press & Media
News and Press Releases
Media library
Contact
Jobs & Careers
About us
BERLIN-CHEMIE
Manufacturing & Quality assurance
Business Development
MENARINI Group
Our History
Our Goal
Executive Board
Responsibility
Code of Conduct
Sustainability & social commitment
Code of practice for business partners
Press & Media
News and Press Releases
Media library
Contact
Jobs & Careers
Home >>
Contact >>
Purchasing Terms >>
Quality Requirements API / EXC >>
Data Protection Information Notice for Healthcare Professionals >>
Data Protection Information Notice for Patients >>
Privacy >>
Disclaimer >>
Imprint >>
Sitemap >>
Change cookie settings »
Press & Media
|
News and Press Releases
|
News Detail
News and Press Releases
Media library
Helsinn Group grants exclusive licensing rights to MENARINI for Pracinostat
12/21/2018
Read more
Art in a click: MENARINI launches “Pills of Art”
10/25/2018
Read more
BERLIN-CHEMIE consistent with sustainability goals of United Nations
9/27/2018
Read more
MENARINI announces new governance
3/22/2018
Read more
MENARINI hires their 17.000th employee
3/15/2018
Read more
MENARINI increases number of members of the board - for the first time external members in majority
6/29/2017
Read more
Selvita and Menarini Group Announce Global License Agreement for Clinical Stage Oncology Drug PIM/FLT3 Inhibitor SEL24
3/28/2017
Read more
Menarini arrives in Columbia and Peru
3/20/2017
Read more
Menarini in Turkey: + 25% Growth in 2016 and New Headquarters in Istanbul
1/18/2017
Read more
Menarini acquires CELLSEARCH business from American group Janssen Diagnostics, pioneer in high-tech cancer diagnostics
12/20/2016
Read more
1
2
3
4
LAST NEWS
BERLIN-CHEMIE: 45 years of inclusion and success of people with disabilities with the Social Enterprise Department
12/1/2023
Read more
The Dates of the XXVII Edition of the International Fair Play Menarini Awards
4/14/2023
Read more
Stemline Therapeutics, a subsidiary of Menarini Group, Receives U.S. FDA Approval for ORSERDUTM (elacestrant) as the First and Only Treatment Specifically Indicated for Patients with ESR1 Mutations in
1/30/2023
Read more
Ibuprofen suspension – exemption to safeguard supply of the population
1/2/2023
Read more
News archive
Archive
Expand/Collapse
2023
(4)
2023, December
(1)
2023, April
(1)
2023, January
(2)
Expand/Collapse
2022
(5)
2022, October
(1)
2022, September
(1)
2022, July
(1)
2022, May
(2)
Expand/Collapse
2021
(3)
2021, November
(1)
2021, October
(1)
2021, April
(1)
Expand/Collapse
2020
(7)
2020, November
(1)
2020, October
(1)
2020, July
(1)
2020, June
(2)
2020, May
(1)
2020, January
(1)
Expand/Collapse
2019
(1)
2019, September
(1)
Expand/Collapse
2018
(5)
2018, December
(1)
2018, October
(1)
2018, September
(1)
2018, March
(2)
Expand/Collapse
2017
(4)
2017, June
(1)
2017, March
(2)
2017, January
(1)
Expand/Collapse
2016
(6)
2016, December
(2)
2016, November
(1)
2016, October
(1)
2016, May
(1)
2016, March
(1)
Responsibility >>
BERLIN-CHEMIE
International >>
SCROLL TO TOP